This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
A multicenter study has described and validated a new strategy for guiding ablation procedures in patients with complex tachycardias. Ablation procedures use energy—usually heat or cold—to eliminate small areas of heart tissue that cause pathological cardiac arrhythmias, thereby restoring normal heartrhythm.
milla1cf Wed, 06/19/2024 - 20:57 June 19, 2024 — When electrophysiologist Eugenio Cingolani, MD , isn’t seeing patients, he can usually be found in his laboratory, investigating improved treatments for heartrhythm disorders. Photo by Cedars-Sinai. Q: How quickly might we see a clinical trial for patients?
The electrical conduction system [1] In schematic depiction of a normal sinus rhythm the P-wave represents atrial depolarization, the QRS complex symbolizes ventricular depolarization, and the T-wave indicates ventricular repolarization. Sinus tachycardia – sinus rhythm above 100 bpm is a sinus tachycardia.
The Role of Wearable Technology in Heart Health Wearable tech is designed to monitor physiological data and provide actionable insights to users. For heart health, these devices use advanced sensors to track metrics like heart rate, blood oxygen levels, and even irregular heartrhythms.
HeartRhythm [Internet]. Even with tachycardia and a paced QRS duration of ~0.16 Bogossian H, Frommeyer G, Ninios I, Hasan F, Nguyen QS, Karosiene Z, Mijic D, Kloppe A, Suleiman H, Bandorski D, et al. New formula for evaluation of the QT interval in patients with left bundle branch block. 2014;11:22732277. J Am Coll Cardiol.
Volta Medical has announced it has entered into a Joint Development Agreement with GE Healthcare to enhance arrhythmia procedures with artificial intelligence (AI)-driven electrophysiology technologies. Our mission to combat complex heartrhythm diseases relies on optimizing interoperability.
milla1cf Fri, 05/17/2024 - 18:54 May 17, 2024 — Royal Philips , a global leader in health technology, is presenting new retrospective study results demonstrating the clinical and economic benefits of Philips’ AI-powered cardiac care solutions at the HeartRhythm Annual Meeting in Boston (May 16-19).
What arrhythmia is present? Let's first consider the heart rate: with a heart rate of 194 beats/min, the heart rate is too low for atrial flutter (1:1) (except in patients who have been pre-treated with medication), and the rate would be unusually high for atrial flutter with 2:1 conduction.
Unlike paroxysmal AF, which describes symptoms that last for seven days or fewer, persistent AF is a sustained arrhythmia that lasts for more than a week 1. Early treatment of persistent AF can reduce the risk of blood clots, stroke, and heart failure, and may prevent the disease from becoming permanent.
Cardioversion is used to correct abnormal heartrhythms, also known as arrhythmias. When your heart beats too quickly, too slow, or irregularly, it can affect your blood flow and lead to severe complications like stroke or heart failure. Cardioversions can help “reset” your heartrhythm to its regular pattern.
This strip was obtained: Apparent Wide Complex Tachycardia at a rate of 280 What do you think? He cardioverted to sinus rhythm, and a 12-lead was obtained. Troponins 34>33>43, likely secondary to myocardial injury from tachycardia. BUT — Today's initial rhythm is much faster = about 280/minute!
ECG is consistent with severe hypokalemia and/or hypomagnesemia causing prolonged QT (QU) at high risk of Torsades (which is polymorphic ventricular tachycardia in the setting of a long QT interval). Polymorphic Ventricular Tachycardia Long QT Syndrome with Continuously Recurrent Polymorphic VT: Management Cardiac Arrest.
a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTech , today announced European CE mark approval of the VARIPULSE Platform for the treatment of symptomatic drug refractory recurrent paroxysmal atrial fibrillation ( AF ) using pulsed field ablation (PFA). [ii]
Otherwise vitals after intubation were only notable for tachycardia. An initial EKG was obtained: Computer read: sinus tachycardia, early acute anterior infarct. Prior to Mizusawa's study, it was thought that the incidence of syncope, arrhythmia, or SCD in this cohort was low [7]. HeartRhythm, 13(7): 1515-1520. [2]:
Brugada Syndrome: Diagnosis and Risk Stratification Hello friends, this is the modified version of my talk at Indian HeartRhythm Society Conference, New Delhi, 2023, on Brugada Syndrome. This is the proposed mechanism of precipitation of arrhythmias in Brugada syndrome during febrile episodes. HeartRhythm.
Notice there is tachycardia. I have warned in the past that one must think of other etiologies of ischemia when there is tachycardia. In this case, the patient had failed to take his atenolol in the AM and was having reflex tachycardia in addition to ACS. But we are now concerned with the precordial leads. BP was 160/100.
Learning points : Takotsubo can lead to cardiac arrest from ventricular arrhythmia. But there are 3 other wide beats in the tachycardia that begins with beat #6 ( = beats #7; 13,14 ). The QTc then gradually shortened over the course of several days as is usual for stress cardiomyopathy.
Antiarrhythmic Drugs WHAT THEY DO : Antiarrhythmic drugs are used to help prevent or treat abnormal heartrhythms, such as atrial fibrillation and ventricular tachycardia. The most common antiarrhythmic drugs for children with congenital heart disease (CHD) include beta-blockers (see above) and sodium channel blockers.
There is sinus tachycardia and also a large R-wave in aVR. Drug toxicity , especially diphenhydramine , which has sodium channel blocking effects, and also anticholinergic effects which may result in sinus tachycardia, hyperthermia, delirium, and dry skin. HeartRhythm 2016. HeartRhythm 2018.
While traditionally described as “benign early repolarization”, they have been associated with J wave syndromes along with Brugada syndrome, causing ventricular arrhythmias (1, 2). HeartRhythm 2010 Hudzik B, Gasior M. The relationship between J wave and ventricular tachycardia during Takotsubo cardiomyopathy.
Landiolol Approval Date: November 22, 2024 Indication: Approved for the treatment of supraventricular tachycardia (SVT). Significance: Landiolol offers a new, highly selective beta-1 blocker for managing abnormally fast heartrhythms, addressing an important need in cardiac health management. Placebo: 0%-11%. Placebo: 1%.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content